Carlsbad-based Vertiflex – maker of a device that reduces spine pressure – was acquired by Boston Scientific. The deal includes Boston Scientific paying $465 million upfront, with additional payments dependent on commercial milestones over the next three years.
medicine: Costs To Scale Up Leave Some Cos. in the Red
The heavy-hitters of San Diego medtech — Dexcom, ResMed, Tandem Diabetes Care and NuVasive — saw revenue either rise or shoot up in recent quarterly results.
A drug candidate from Poseida Therapeutics aimed at relapsed multiple myeloma has picked up an orphan drug designation.
Genomics titan Illumina has filed a patent infringement lawsuit against a BGI Group subsidiary.
Health: Company Is Working on Getting Therapeutics Into Cell
DTx Pharma, a Torrey Pines startup developing a way to make more effective RNA treatments, recently raised $3 million in Series A funding. The round included investments from previous investors, including Tech Coast Angels and Friedman Bioventure.
life science: Also On the Move, BioLegend Claims Entire Street
Two biotechs, Takeda Pharmaceutical Co. and BioLegend, recently opened new campuses in San Diego.
TECH: VC Led $5.3M Round for MedCrypt
Section 32, the local venture fund started by former Google Ventures founder Bill Maris, made its first San Diego investment May 7. The firm led a $5.3 million Series A round in MedCrypt, a San Diego cybersecurity startup that helps medical device vendors ensure their devices are secure. Previous investors Eniac Ventures and Y Combinator also participated in the round.
HEALTH CARE: Florida Firm Gives It Telehealth Capabilities
AMN Healthcare’s recently announced acquisition will expand its footprint in fast-growing markets, while positioning the nation’s largest health staffing firm for what could be the wave of the future.
Wuxi Apptec earlier this month bought San Diego-based Pharmapace, the latest in consolidation among niche players in the drug development market.
Nancy Hong joined RiverVest in 2016 when the Midwest-based venture capital firm opened its San Diego office.
Researchers at UC San Diego were awarded $4.7 million in grants to identify therapeutics and improve surgery for Chrohn’s disease.
LunaDNA, which is building a platform for users to share their health data, closed a $4.6 million round.
San Diego-based MabVax Therapeutics sold its cancer drug assets and its lab equipment to BioNTech, it was announced May 8.
San Diego-based Halozyme reported $56.9 million in first quarter revenue, an 84 percent year-over-year increase.
MedCrypt, a medical device security startup, raised $5.3 million led by local VC firm Section 32.